Merck Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Evie Yulin

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure4.9yrs
CEO ownershipn/a
Management average tenure8.3yrs
Board average tenure13.9yrs

Recent management updates

Recent updates


CEO

Evie Yulin (57 yo)

4.9yrs

Tenure

Ms. Evie Yulin serves as President Director at PT Merck Tbk since January 2020 and serves as its Biopharma Director. She served as a Business Unit Director of PT Astra Zeneca Indonesia and Marketing Direct...


Leadership Team

NamePositionTenureCompensationOwnership
Evie Yulin
President Director & Biopharma Director4.9yrsno datano data
Bambang Nurcahyo
Finance Director & Director15.7yrsno datano data
Eduan Tjong
Supply Chain & Operation Managerno datano datano data
Miranda Andamsari
Compliance Officerno datano datano data
Taufiq Wibowo
Head of Legalno datano datano data
Melisa Sandrianti
Corporate Secretary & Corporate Communications Manager6.9yrsno datano data
Aquira Moeladi
Human Resource Headno datano datano data
Arryo Aritrixso Teguh Wachjuwidajat
Plant Director & Independent Director9.7yrsno datano data
Pachita Ramadhani
Head of Internal Audit Unit & Sr Finance Managerno datano datano data
Bundi Jannius
Head of Site Pharma Techno datano datano data
Reny Sitohang
Head of Quality Operationno datano datano data
Arief Oesman
Head of Information Technologyno datano datano data

8.3yrs

Average Tenure

52yo

Average Age

Experienced Management: MERK's management team is seasoned and experienced (8.3 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Evie Yulin
President Director & Biopharma Director13.9yrsno datano data
Bambang Nurcahyo
Finance Director & Director15.7yrsno datano data
Arryo Aritrixso Teguh Wachjuwidajat
Plant Director & Independent Director9.7yrsno datano data
Parulian Simanjuntak
Independent Commissioner21.6yrsno datano data
Mei Tang
President Commissioner7.7yrsno datano data

13.9yrs

Average Tenure

57yo

Average Age

Experienced Board: MERK's board of directors are seasoned and experienced ( 13.9 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 00:38
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

PT Merck Tbk is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution